Your browser doesn't support javascript.
loading
Risk factors for chronic kidney disease following acute kidney injury in pediatric allogeneic hematopoietic cell transplantation.
Prasad, Malavika; Jain, Namrata G; Radhakrishnan, Jai; Jin, Zhezhen; Satwani, Prakash.
Afiliação
  • Prasad M; Division of Pediatric Nephrology, Columbia University Medical Center, New York, NY, USA.
  • Jain NG; Division of Pediatric Nephrology, Department of Pediatrics, University of Louisville, Louisville, KY, USA.
  • Radhakrishnan J; Division of Pediatric Nephrology, Columbia University Medical Center, New York, NY, USA.
  • Jin Z; Division of Nephrology, Department of Medicine, Columbia University Medical Center, New York, NY, USA.
  • Satwani P; Department of Biostatistics, Columbia University Mailman School of Public Health, New York, NY, USA.
Bone Marrow Transplant ; 56(7): 1665-1673, 2021 07.
Article em En | MEDLINE | ID: mdl-33627796
ABSTRACT
Risk factors associated with the progression of acute kidney injury to chronic kidney disease in pediatric allogeneic hematopoietic cell transplantation (AlloHCT) recipients are not well described. We retrospectively investigated the risk factors for the progression to CKD in 275 AlloHCT recipients. AKI and CKD grading was defined according to the Kidney Disease Improving Global Outcomes classification. PRI90 was defined as persistent renal insufficiency (estimated GFR < 90 ml/min/1.73 m2) 90 days after the first episode of AKI. The median age was 9.1 years. Incidence of stages 1, 2, and 3 AKI were 43%, 41%, and 15%, respectively. 86.1% met our study criteria for PRI90. Of the 236 PRI90 patients, 213 and 152 patients were evaluable for CKD at 1 and 3 years, respectively. The incidence of CKD at 1 and 3 years was 63.1% and 62.9%, respectively. On multivariable analysis, estimated GFR at initial episode of AKI (<80 ml/min/1.73 m2) and estimated GFR (<70 ml/min/1.73 m2) at PRI90 was a risk factor associated with CKD development and both risk factors were associated with significantly lower overall survival. To conclude, eGFR at the time of AKI and PRI90 may be considered for screening pediatric AlloHCT recipients at risk for the progression to CKD.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Insuficiência Renal Crônica / Injúria Renal Aguda Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Insuficiência Renal Crônica / Injúria Renal Aguda Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article